Sesen Bio Inc (NASDAQ:SESN)
| 0.6384 Delayed Data As of Jan 27 |  +0.0248 / +4.04%Today’s Change | 0.37 Today|||52-Week Range 0.97 | +4.74% Year-to-Date |
Latest SESN News | Press Releases
No recent news for Sesen Bio Inc.
Today’s Trading
| Previous close | 0.61 |
| Today’s open | 0.61 |
| Day’s range | 0.61 - 0.64 |
| Volume | 10,186 |
| Average volume (3 months) | 1,122,024 |
| Market cap | $125.7M |
Data as of 3:40pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +99.06% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +136.24% |
| P/E ratio | NM |
| Price/Sales | 5.60 |
| Price/Book | 0.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTNBMatinas BioPharma Ho... | +0.01 | +1.19% |
| PRPHProphase Labs Inc | 0.00 | 0.00% |
| AKBAAkebia Therapeutics ... | 0.00 | 0.00% |
| EPIXESSA Pharma Inc | +0.10 | +3.73% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | March 22, 2023 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $26.5M |
| Annual profit (last year) | -$336.0K |
| Net profit margin | -1.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
